Terns Pharmaceuticals, Inc. · NASDAQ:TERN
Morgan Stanley's stake in Terns Pharmaceuticals, Inc. fell to 5.60% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 12, 2026
Morgan Stanley's stake in Terns Pharmaceuticals, Inc. fell to 5.60%, 6,433,964 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G/A).
- Stake
- 5.60%
- Shares
- 6,433,964
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 5.60% | 6,433,964 |
| Morgan Stanley Capital Services LLC | 4.90% | 5,764,462 |
Source
Related
- Terns Pharmaceuticals, Inc.
- Morgan Stanley
- Terns Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G · Morgan Stanley · May 7, 2025
- Schedule 13G/A · Adage Capital Management, L.P. · May 13, 2026
- Form 4 · Kuriakose Emil · May 5, 2026
- Form 4 · Gengos Andrew · May 5, 2026
- Form 4 · Burroughs Amy L. · May 5, 2026
- Form 4 · Kuriakose Emil · Apr 2, 2026